Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by studpuppyon Aug 11, 2011 8:52pm

228 Views

Post# 18933677

RE: Some clients got tired of waiting

immo,nothing is going to happen by this fall and that clown will still be there, trust me he`s not going anywhere anytime soon so isn`t TH, best case scenario is back up to $5 or $6, since he took over all he did is create new 52week lows back to back and lost almost at one point over $3 a share! what a schmuck..he is our marketing genius wow
regards stud

Bullboard Posts

Changing Europe’s dependency on HREE from China